Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in Advanced Stages of Type 2 Diabetes: A Randomized Controlled Trial.

Source: Kempf, K., et al. 2017 - Pubmed ID: 28500214

Setting: Germany, Attending physician

Study design:

RCT

Follow up: 52 weeks.

Patient group:

Sample size:

Total: 202 ( 133)

IG: 102 (77)

CG: 100 (56)

 

Inclusion criteria:

– Diabetes type 2

– Overweight or obese

Type of technology:

Home monitoring equipment

– weighing scale

– step counter

– Blood glucose meter.

 

TeLiPro device (online portal)

– Data upload and Data transfer

 

Phone call

– Information

– Guidance

Intervention:

Intervention:

Patients monitor and transfer their clinical data via TeLiPro device. Diabetes coaches calls patient weekly for discussion of measured data and for diabetes relevant information

Duration: 12 weeks

Add on: NA

 

Control group: routine health care visits

Clinical effect/ Patient safety:

Clinical effect:

– HbA1c ↓

– body weight ↓

– BMI ↓

– Bp ↓

– physical health ↑

– Cognitive control ↑

– medication demands ↓

Patient safety:

No adverse events were reported

Patient experiences/ Staff experiences:

Patient experiences:

NA

Staff experiences:

NA

Costs and organization:

Investment:

Home monitoring equipment

– Glucometer

– Weight

– step counter

Running:

Staff resources

– weekly care calls

Organization:

NA

Health care utilization:

NA

Scroll to Top

Information

“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)